EVEREST II Pivotal Study High Risk Registry (HRR)

计划入组 78 人 · 首次发布于 2013 年 9 月 12 日

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

计划入组 342 人 · 首次发布于 2026 年 1 月 21 日

A Study of EXG102-031 in Patients With wAMD (Everest)

计划入组 6 人 · 首次发布于 2023 年 6 月 15 日

Glomerulonephritis(Everest Medicines)

mRNA rabies vaccine

mRNA Prophylactic Vaccine(Everest Medicines)

EVEREST MEDICINES (SINGAPORE) PTE. LTD.

Singapore

EVEREST PESQUISA E DESENVOLVIMENTO LTDA

Brazil

Everest Medicines II (HK) Limited

Hong Kong, China

Taiwan Accepts Everest Medicines' VELSIPITY Application for Ulcerative Colitis Treatment

Everest Medicines Advances AI-Powered mRNA Platform with Cancer Vaccine Breakthroughs

FDA Clears Everest Medicines' IND Application for Novel mRNA Cancer Vaccine EVM14